Santos da Silva Jorge

Santos da Silva Jorge is listed in filings as Chief Executive Officer at MoonLake Immunotherapeutics. This profile follows SEC Form 4 activity through Apr 14, 2026, including sale activity. Recent filings connect the profile to MoonLake Immunotherapeutics (MLTX). The current snapshot covers public activity from Mar 3, 2025 to Apr 14, 2026. Reported amounts are shown as $1.0M to $5.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.